Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Shatavari Root Extract for Perimenopausal Symptoms [NA]

View source ↗

Summary

This ClinicalTrials.gov entry notes a not-yet-recruiting study evaluating Shatavari Root Extract for perimenopausal symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shatavari Root Extract (Asparagus racemosus extract)

Snippet

Sponsor: SF Research Institute, Inc. | Conditions: Perimenopause, Women Health | NA | Status: NOT_YET_RECRUITING